InvestmentAug 7, 2026, 09:32 AM
Femasys Secures $30M Private Placement; Potential $60M from Warrants
AI Summary
Femasys Inc. announced a $30 million private placement with accredited investors, led by Nantahala Capital, including Rosalind Advisors and Femasys management. The company is selling 9,374,999 shares of common stock and pre-funded warrants, along with 18,749,998 accompanying warrants. This financing could potentially bring in an additional $60 million upon full cash exercise of the warrants. The funds are intended to significantly strengthen the balance sheet and provide capital to execute Femasys' business plan, including advancing its fertility portfolio and FemBloc clinical and regulatory programs.
Key Highlights
- Secured $30 million in private placement financing.
- Financing led by Nantahala Capital, with Rosalind Advisors and Femasys management participating.
- Issued 9,374,999 shares of common stock and pre-funded warrants.
- Issued 18,749,998 accompanying warrants.
- Purchase price of $3.20 per share of common stock/warrant.
- Potential to receive up to an additional $60 million from full cash exercise of warrants.
- Proceeds will strengthen balance sheet and fund fertility portfolio and FemBloc program.
Price Impact
More from FEMY